Category: Biotechnology

wad of us dollars

August 6, 2020

Biotechnology Awards NC Biotech Center invested nearly $2M in state’s life science sector

The North Carolina Biotechnology Center awarded 34 grants and loans...

MORE >
NC Biotech Center office building

February 10, 2020

Biotechnology NCBiotech awards $2.1M in grants, loans

The North Carolina Biotechnology Center has awarded 23 grants and loans...

MORE >
Innavasc President & CEO, Joe Knight, along with Senior Development Engineer, Craig Nichols and founder, Shawn Gage met with President Price to show him InnAVasc's puncture proof vascular graft. Photo by Jared Lazarus/Duke Photography

December 7, 2018

Biotechnology Start-ups Awards NCBiotech Awards $500K to InnAVasc

A $500,000 loan from the North Carolina Biotechnology Center will help...

MORE >
CRISPR Gene Image

September 26, 2019

Biotechnology Start-ups New CRISPR class expands genetic engineering toolbox

Biomedical engineers at Duke University have used a previously unexplored...

MORE >

November 3, 2021

Biotechnology Start-ups Awards Nucleate will Award up to $1.5 Million to Biotech Founders in Partnership with Petri

Nucleate, the nonprofit organization led by academic trainees and dedicated...

MORE >
Nasdaq

March 4, 2019

Biotechnology Start-ups Off-the-shelf CAR-T and gene-editing player Precision Bio files $100M IPO

Precision BioSciences is looking to raise up to $100 million...

MORE >

January 16, 2020

Biotechnology Start-ups PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused...

MORE >
Phasebio Logo

February 10, 2020

Biotechnology Start-ups PhaseBio Announces Case Study Highlighting PB1046 Hemodynamic Data

Presented at the 14th Pulmonary Vascular Research Institute World Congress...

MORE >

January 16, 2020

Biotechnology Start-ups PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused...

MORE >